ALTEOGEN Inc. (KOSDAQ:196170)

Theseus Pharmaceuticals Revenue

ALTEOGEN had revenue of 83.70B KRW in the quarter ending March 31, 2025, with 139.81% growth. This brings the company's revenue in the last twelve months to 151.65B, up 25.24% year-over-year. In the year 2024, ALTEOGEN had annual revenue of 102.85B with 6.56% growth.

• Revenue (ttm): 151.65B
• Revenue Growth: +25.24%
• P/S Ratio: 152.24
• Revenue / Employee: 978.39M
• Employees: 155
• Market Cap: 23.09T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	102.85B	6.33B	6.56%
Dec 31, 2023	96.52B	67.72B	235.08%
Dec 31, 2022	28.81B	-9.94B	-25.65%
Dec 31, 2021	38.75B	-3.68B	-8.67%
Dec 31, 2020	42.43B	13.20B	45.15%